4
Apr
2019
Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer
GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a... Read More
9
May
2018
Fighting cancer is a team effort
/
By Dr. Peter A. Jones and Dr. Steve Baylin Co-leaders, Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team
30
Nov
2017
Clinical trial investigates possible triple threat for lung cancer
/
A first-of-its-kind combination of medications may enable the immune system to better combat lung cancer, which claims more lives than any other... Read More
12
Oct
2017
A Catalyst for combating cancer
/
Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr.... Read More
10
Oct
2016
Combinations and collaborations in the fight against cancer: An interview with Dr. Feyruz Rassool and Dr. Stephen Baylin
/
What happens when scientists collaborate rather than compete? In this case, the result is a combination of two drugs that may be... Read More
29
Aug
2016
Vitamin C may boost effectiveness of acute myeloid leukemia treatment
/
EDITOR’S NOTE: Maintaining proper nutrition is an important part of cancer therapy. Patients are urged to consult their doctors before making any... Read More
26
Feb
2015
Van Andel Research Institute appoints leading cancer scientist Dr. Stephen Baylin as professor
/
GRAND RAPIDS, Mich. (Feb. 26, 2015)—Renowned cancer scientist and epigenetics expert Stephen Baylin, M.D., has accepted an appointment at Van Andel Research Institute... Read More
20
Oct
2014
Stand Up To Cancer Epigenetics Dream Team continues with $7.5 million funding from Van Andel Research Institute
/
Grand Rapids, Michigan (October 20, 2014)— The work of one of the Stand Up To Cancer (SU2C) inaugural Dream Teams, launched in... Read More